Manufacturer
25 recalls in our database name Valeant Pharmaceuticals North America LLC as the manufacturing or recalling firm.
Of the 25 recalls from Valeant Pharmaceuticals North America LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (4%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Valeant Pharmaceuticals is recalling 22 bottles of Cardizem CD capsules because they failed to meet dissolution specifications, potentially affecting drug release.
Valeant Pharmaceuticals is recalling 390 bottles of Cardizem CD capsules because they failed to meet dissolution specifications, potentially affecting drug release.
Valeant Pharmaceuticals is recalling 206 bottles of Cardizem CD capsules because they failed to meet dissolution specifications, meaning the drug may not release properly.
Valeant Pharmaceuticals is recalling 1,023 bottles of Cardizem CD (diltiazem hydrochloride) 120 mg capsules because they failed to meet dissolution specifications.
Valeant Pharmaceuticals is recalling 23,884 bottles of Diltiazem HCl CD capsules because they failed dissolution specifications, potentially affecting drug release.
Valeant Pharmaceuticals is recalling specific lots of Cortaid Maximum Strength Cream due to current Good Manufacturing Practice (cGMP) deviations identified during a supplier review.
Valeant Pharmaceuticals is recalling specific lots of Cortaid Intensive Therapy Cooling Spray due to cGMP deviations identified after a supplier recall for microbial contamination.
Valeant Pharmaceuticals is recalling 5,016 tubes of Cortaid 12-Hour Advanced Anti-itch Cream due to current Good Manufacturing Practice (cGMP) deviations identified during a supplier review.
Valeant Pharmaceuticals is recalling 306 cartons of Diazepam Rectal Gel because the outer cartons are missing lot numbers and expiration dates.
Valeant Pharmaceuticals is recalling 844 bottles of Obagi-C Rx System C-Therapy Night Cream because the bottles are missing the product insert and outer carton containing safety instructions.
Valeant Pharmaceuticals is voluntarily recalling CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment due to discoloration.
Valeant Pharmaceuticals is voluntarily recalling 5,647 units of CLENZIderm M.D. Acne Treatment Systems nationwide due to product discoloration.
Valeant Pharmaceuticals is recalling 958 bottles of SECONAL SODIUM capsules because the package insert is missing a warning regarding anaphylaxis.
Valeant Pharmaceuticals is recalling 3,827 bottles of Lodrane D capsules because the outer cartons were mislabeled with the wrong active ingredient.
Valeant Pharmaceuticals is recalling specific lots of Chlordiazepoxide HCl/Clidinium Bromide capsules because they failed impurities and degradation specifications.
Valeant Pharmaceuticals is recalling specific lots of Librax capsules because they failed impurity and degradation specifications.
Valeant Pharmaceuticals is recalling 61 units of the SPAG-2 6000 aerosol generator because they were released without required particle size testing.
Valeant Pharmaceuticals is recalling specific bottles of Fenoglide (fenofibrate) 120 mg tablets because they failed 24-month dissolution testing.
Valeant Pharmaceuticals is recalling Nifedipine Extended-Release Tablets, 90 mg, because some lots failed dissolution specifications.
Valeant Pharmaceuticals is recalling Virazole (ribavirin) inhalation solution due to positive microbial contamination found during stability testing.
Valeant Pharmaceuticals is recalling APLENZIN extended-release tablets because the package insert is incorrect or missing. Consumers should contact their healthcare provider.
Valeant Pharmaceuticals is recalling APLENZIN (bupropion hydrobromide) extended-release tablets because the package insert is incorrect or missing.
Valeant Pharmaceuticals is recalling 20,499 bottles of APLENZIN (bupropion hydrobromide) 174 mg tablets because the package insert is incorrect or missing.
Valeant Pharmaceuticals is recalling Vaseretic tablets because they were packaged with the incorrect version of the package insert.
Valeant Pharmaceuticals is recalling 205,853 bottles of Vasotec (enalapril maleate) tablets because they were packaged with the incorrect version of the package insert.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Valeant Pharmaceuticals (United States)
Source: Wikidata (Q29122989), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.